- Dr. Thibonnier is the Founder and President of AptamiR Therapeutics, Inc. As a Physician-Scientist, he led a successful career in academic medicine in France and the USA up to the rank of tenured Professor of Medicine and Pharmacology, followed by several years in executive leadership positions at major Pharmaceutical Companies (Bayer Health Care, BMS, and GSK) and two Biotechnology Startup Companies, overseeing cardiovascular and metabolic drugs development from candidate selection to regulatory approval.
- Dr. Thibonnier earned a M.D. degree with High Honors from the Université Pierre et Marie Curie in Paris, France and a M.Sc. in Pharmacology from the University of California, San Francisco where he completed his fellowship in clinical pharmacology. He trained in Endocrinology, Nephrology and Clinical Pharmacology.